Wird geladen...
Irreversible electroporation and the pancreas: What we know and where we are going?
Pancreatic adenocarcinoma continues to have a poor prognosis with 1 and 5 years survival rates of 27% and 6% respectively. The gold standard of treatment is resection, however, only approximately 10% of patients present with resectable disease. Approximately 40% of patients present with disease that...
Gespeichert in:
| Veröffentlicht in: | World J Gastrointest Surg |
|---|---|
| 1. Verfasser: | |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
Baishideng Publishing Group Inc
2015
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4550840/ https://ncbi.nlm.nih.gov/pubmed/26328033 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4240/wjgs.v7.i8.138 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|